Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(88)
•••
Comment by INVSTIGAT0Ron Jun 03, 2019 7:36am
155 Views
Post# 29793204

RE:RE:Another positive article today

RE:RE:Another positive article today
ghkane wrote:
ghkane wrote: https://finance.yahoo.com/news/aphria-buy-180000633.html So is Aphria considered a buy ? This analysis/ report says yes. But I am really surprised that the verdict section did not mention that Aphria has created their impressive operation with less than $2 billion whereas Aurora and Canopy have market caps of $10 billion and $22 billion respectively. And Aphria will also have an impressive partner soon immediately following the Health Canada licence approval for Aphrias Double Diamond operation.


https://finance.yahoo.com/news/aphria-buy-180000633.html

Here is the article.
Is anybody else getting excited?



Nobody is excited and nobody is delusional as you are besides Savage. You call out bashers for spreading false info yet here you are with yet another outright lie about a partnership deal following HC news. You're the same person who kept saying the exact same thing about phase IV HC news. You're useless.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities